Cholecyst-derived extracellular matrix (CEM) is a novel, proteinaceous biomaterial, derived from the porcine cholecyst, which may have potential applications as a scaffold in the area of heart valve tissue engineering. In this study the potential of CEM to support the proliferation of valvular endothelial cells (VECs) and valvular interstitial cells (VICs), while maintaining their phenotypic mRNA synthesis, protein expression and morphology was assessed by biochemical assays, electron microscopy, immunostaining and reverse-transcriptase polymerase chain reaction. VICs and VECs were isolated from the porcine aortic valve and techniques were developed for the isolation of CEM for cell culture. VECs and VICs cultured on CEM adhered and proliferated, maintaining their phenotypic morphology. VECs synthesised von Willebrand factor mRNA and endothelial nitric oxide synthase (eNOS) mRNA and expressed eNOS and VICs synthesised alpha-smooth muscle actin (alphaSMA) mRNA and expressed alphaSMA. Cellular area fraction of VICs expressing alphaSMA was 87.7+/-6.8% and cellular area fraction of VECs expressing eNOS was 93.8+/-9.3%. Findings of this study support the hypothesis that CEM is a potential biomaterial for tissue engineered heart valve scaffold design.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2006.11.030DOI Listing

Publication Analysis

Top Keywords

cholecyst-derived extracellular
8
extracellular matrix
8
valvular endothelial
8
valvular interstitial
8
interstitial cells
8
heart valve
8
maintaining phenotypic
8
mrna expressed
8
cellular area
8
area fraction
8

Similar Publications

Compromised angiogenesis is a major factor contributing delayed wound healing in diabetic patients. Graft-assisted healing using synthetic and natural scaffolds supplemented with micromolecules for stimulating angiogenesis is the contemporary tissue engineering strategy for treating diabetic wounds. This study deployed the carbodiimide chemical reaction for coupling gelatin with a porcine cholecyst-derived scaffold (CDS) for enhancing angiogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the development of hybrid hydrogels for tissue engineering by combining extracellular matrix (ECM) from porcine cholecyst with synthetic poly(ethylene glycol) diacrylate (PEGDA) at various concentrations.
  • The combination of C-ECM and PEGDA was achieved through chemical processes, resulting in hydrogels with improved mechanical properties suitable for skeletal muscle tissues.
  • Evaluations revealed that certain PEGDA concentrations (0.2% and 0.5%) were biocompatible, promoting cell growth and showing potential for future tissue engineering applications.
View Article and Find Full Text PDF

In regenerative medicine, despite the chances of graft-rejection, scaffolds prepared from extracellular matrices of various mammalian organs/tissues are widely used. Graft-assisted healing of full thickness skin-wounds is a major use of these bioscaffolds. Therefore, considering its prospective clinical use as a wound healing matrix, this study evaluated the healing potential of porcine cholecyst-derived scaffold (CDS) prepared by a non-detergent/enzymatic method for treating naturally occurring full thickness lacerated wounds in dogs.

View Article and Find Full Text PDF

Abdominal wall repair frequently utilizes either nondegradable or biodegradable meshes, which are found to stimulate undesirable biological tissue responses or which possess suboptimal degradation rate. In this study, a biologic mesh prototype made from carbodiimide cross-linked cholecyst-derived extracellular matrix (EDCxCEM) was compared with small intestinal submucosa (Surgisis), cross-linked bovine pericardium (Peri-Guard), and polypropylene (Prolene) meshes in an in vivo rabbit model. The macroscopic appearance and stereological parameters of the meshes were evaluated.

View Article and Find Full Text PDF

A gold nanoparticle coated porcine cholecyst-derived bioscaffold for cardiac tissue engineering.

Colloids Surf B Biointerfaces

September 2017

Division of Experimental Pathology, Department of Applied Biology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695012, India. Electronic address:

Extracellular matrices of xenogeneic origin have been extensively used for biomedical applications, despite the possibility of heterogeneity in structure. Surface modification of biologically derived biomaterials using nanoparticles is an emerging strategy for improving topographical homogeneity when employing these scaffolds for sophisticated tissue engineering applications. Recently, as a tissue engineering scaffold, cholecyst derived extracellular matrix (C-ECM) has been shown to have several advantages over extracellular matrices derived from other organs such as jejunum and urinary bladder.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!